Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ZNTL | Zentalis Pharmaceuticals, Inc. | Director | $1.07M | -$125K | -10.5% | Jun 21, 2024 |
GLUE | Monte Rosa Therapeutics, Inc. | Director | Jun 12, 2024 | |||
TRIL | Trillium Therapeutics Inc. | President and CEO, Director | Nov 17, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|